Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2021-05-12 13:00:00
Reporting Period:
Accepted Time:
2021-05-12 16:09:40
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1417926 Invo Bioscience Inc. INVO Surgical & Medical Instruments & Apparatus (3841) 204036208
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535264 Awm Investment Company, Inc. 527 Madison Avenue
Suite 2600
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-10 1,000 $3.76 1,159,075 No 4 P Indirect By Limited Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Limited Partnership
  1. This is a weighted average price
  2. AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Life Sciences Fund, L.P. (LS). (LS and together with QP and Cay, the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 400,559 shares of Common Stock of the Issuer (the Shares) held by QP, 133,516 Shares held by Cay and 625,000 Shares held by LS.
  3. Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM.The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall notbe deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of theSecurities Exchange Act of 1934, as amended, or for any other purpose.